TJ191 - HY-120075
Nur noch %1 verfügbar
Catalog #
HY-120075
Ab
67,00 €
TJ191 is a potent and specific anti-cancer agent that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells. TJ191 has no affects on the proliferation of other cancer cells or normal fibroblasts or immune cells. TJ191 can be used for cancer research[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-120075/TJ191-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 1522415-97-9 |
| Storage | 4°C (Powder, protect from light) |
| MWT | 255.38 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Apoptosis |
| Application: | Cancer-programmed cell death |
|---|